Cargando…

Follow up study of B-lymphocyte depletion in the treatment of patients with systemic lupus erythematosus

Detalles Bibliográficos
Autores principales:	Leandro, MJ, Edwards, JCW, Ehrenstein, MR, Cambridge, G, Isenberg, DA
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834168/ http://dx.doi.org/10.1186/ar1712

Ejemplares similares

Internalization of Rituximab and the Efficiency of B Cell Depletion in Rheumatoid Arthritis and Systemic Lupus Erythematosus
por: Reddy, Venkat, et al.
Publicado: (2015)

Effects of rituximab-based B-cell depletion therapy on skin manifestations of lupus erythematosus – report of 17 cases and review of the literature
por: Hofmann, SC, et al.
Publicado: (2013)

A Phase I trial of B-cell depletion with anti-CD20 monoclonal antibody (rituximab) in the treatment of systemic lupus erythematosus
por: Eisenberg, R, et al.
Publicado: (2003)

Analysis of B-cell subpopulations in systemic lupus erythematosus
por: Dorner, T, et al.
Publicado: (2003)

Disparity in peripheral and renal B-cell depletion with rituximab in systemic lupus erythematosus: an opportunity for obinutuzumab?
por: Reddy, Venkat R, et al.
Publicado: (2021)

Autoantibodies and cognitive impairment in systemic lupus erythematosus
por: Kowal, C, et al.
Publicado: (2004)

Epidemiology of foot complaints in systemic lupus erythematosus
por: Otter, S, et al.
Publicado: (2015)

9.4 Autoantibodies in pediatric systemic lupus erythematosus: ethnic grouping, autoantibody clustering and clinical correlations
por: Jurencak, R, et al.
Publicado: (2008)

Failure of receptor revision in the autoreactive B cells in patients with systemic lupus erythematosus
por: Yoshikawa, H, et al.
Publicado: (2003)

Adverse infusion reactions to rituximab in systemic lupus erythematosus: a retrospective analysis
por: Hennessey, Ashleigh, et al.
Publicado: (2019)

Subclinical cardiovascular abnormalities in patients with juvenile systemic lupus erythematosus
por: Canpolat, Nur, et al.
Publicado: (2011)

O07 Managing relapsing and refractory lupus nephritis in juvenile systemic lupus erythematosus: a case report
por: Javed, Farhan, et al.
Publicado: (2021)

Origins of systemic lupus erythematosus: genes, environment, and host immune response
por: Harley, JB, et al.
Publicado: (2003)

Clinical phenotype of neonatal lupus erythematosus relates to autoantibody level and gender
por: Venkatesan, S, et al.
Publicado: (2011)

Analysis of growth in female patients with pediatric-onset systemic lupus erythematosus
por: Mak, NC, et al.
Publicado: (2011)

Defective removal of ribonucleotides from DNA promotes systemic lupus erythematosus
por: Günther, C, et al.
Publicado: (2015)

Prevalence and demographics of systemic lupus erythematosus and lupus nephritis among US children with Medicaid coverage, 2002-2004
por: Hiraki, Linda T, et al.
Publicado: (2012)

Long-term education and employment outcomes in pediatric-onset systemic lupus erythematosus
por: Lawson, Erica F, et al.
Publicado: (2012)

Foot problems in patients with systemic lupus erythematosus; under-reported and under-treated?
por: Otter, S, et al.
Publicado: (2015)

Pragmatic Treatment of Patients With Systemic Lupus Erythematosus With Rituximab: Long‐Term Effects on Serum Immunoglobulins
por: Reddy, Venkat, et al.
Publicado: (2017)

14.2 Causes of early death in juvenile onset systemic lupus erythematosus (JSLE)
por: Bader-Meunier, B, et al.
Publicado: (2008)

Insights into systemic lupus erythematosus pathogenesis through blood global gene expression analysis
por: Pascual, V, et al.
Publicado: (2004)

Defining clinical remission and clinically inactive disease in juvenile systemic lupus erythematosus (jSLE)
por: Mina, Rina, et al.
Publicado: (2011)

Anti-TNF antibody therapy induces IL-17 suppressing regulatory T cells in patients with rheumatoid arthritis
por: McGovern, Jenny, et al.
Publicado: (2012)

Survival analysis of mortality and development of lupus nephritis in patients with systemic lupus erythematosus up to 40 years of follow-up
por: Luo, Weike, et al.
Publicado: (2022)

PD-L1 expression on monocytes marks active systemic lupus erythematosus in patients without nephritis
por: Stevens, Anne M, et al.
Publicado: (2012)

Native T1 mapping by cardiovascular resonance imaging detects subclinical cardiomyopathy in patients with systemic lupus erythematosus
por: Puntmann, Valentina O, et al.
Publicado: (2013)

Myocardial tissue characterisation with late gadolinium enhancement in rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis
por: Ntusi, Ntobeko A, et al.
Publicado: (2013)

OA14 The role of anifrolumab in treating life threatening systemic lupus erythematosus with severe mucocutaneous involvement
por: Baldwin, Christopher, et al.
Publicado: (2023)

Obinutuzumab induces superior B-cell cytotoxicity to rituximab in rheumatoid arthritis and systemic lupus erythematosus patient samples
por: Reddy, Venkat, et al.
Publicado: (2017)

Safety and efficacy of belimumab after B cell depletion therapy in systemic LUPUS erythematosus (BEAT-LUPUS) trial: statistical analysis plan
por: Muller, Patrick, et al.
Publicado: (2020)

Long-Term Follow-Up of Sepsis Induced Immunoparalysis
por: Raja, M, et al.
Publicado: (2015)

Evaluation of autoantibody profiles in a cohort of new-onset pediatric systemic lupus erythematosus patients using autoantigen microarray technology
por: Balboni, Imelda M, et al.
Publicado: (2012)

Belimumab after B cell depletion therapy in patients with systemic lupus erythematosus (BEAT Lupus) protocol: a prospective multicentre, double-blind, randomised, placebo-controlled, 52-week phase II clinical trial
por: Jones, Alexis, et al.
Publicado: (2019)

Abnormal myocardial perfusion correlates with impaired systolic strain and diastolic strain rate in systemic lupus erythematosus: a cardiovascular magnetic resonance study
por: Ntusi, Ntobeko A, et al.
Publicado: (2015)

19. A case of giant cell arteritis (GCA) co-existent with systemic lupus erythematosus (SLE)/rheumatoid arthritis (RA) overlap syndrome
por: Steward, Matthew, et al.
Publicado: (2019)

O08 A case of juvenile systemic lupus erythematosus with pyrexia of unknown origin
por: Warrier, Kishore, et al.
Publicado: (2021)

3.5 Comparison of functional ability in juvenile idiopathic arthritis, juvenile dermatomyositis, juvenile systemic lupus erythematosus and healthy controls. An analysis of the PRINTO database
por: Filocamo, G, et al.
Publicado: (2008)

Impaired energetics and normal myocardial lipids in rheumatoid arthritis and systemic lupus erythematosus: a phosphorous and proton magnetic resonance spectroscopy and cardiovascular magnetic resonance study
por: Ntusi, Ntobeko A, et al.
Publicado: (2015)

Immune activation, viral replication and mucosal depletion
por: Grossman, Zvi
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_57gtodjbqns1tap4dh2fo2jara